Sachin Pai
Medical Oncology · Mobile, ALNPI 1942512637
Payments from drug & device makers
$2,100,552in general payments, 2019–2025
Across 706 payments — averaging $2975.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1.6M
- Incyte Corporation$522K
- AstraZeneca$7K
- Astellas Pharma US Inc$252
- AbbVie$58
- Eisai Inc.$47
- plus $120 from 7 others
General payments by program year
19
20
21
22
23
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 257 | $1,570,641 |
| Incyte Corporation | 424 | $522,334 |
| AstraZeneca | 4 | $7,100 |
| Astellas Pharma US Inc | 9 | $252 |
| AbbVie | 2 | $58 |
| Eisai Inc. | 2 | $47 |
| Pfizer | 2 | $25 |
| Novartis | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| Seagen Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
| EMD Serono, Inc. | 1 | $12 |
How this compares
$2,100,552 in reported general payments places this provider in the 90th percentile of 30 medical oncology providers in Alabama.
Other medical oncology in Mobile
- Pranitha ProdduturvarMobile$910K
- Norma NordenMobile$2K
- Syed Abbas AliJasper$3M
- Joelle HamiltonHomewood$2.2M
- Marshall SchreederHuntsville$1.1M
- John DubayTuscaloosa$756K
- Sunil RangarajanBirmingham$576K
- James DaughertyFlorence$119K
- Hemant PatelMuscle Shoals$61K
- Johnny NacillaCullman$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.